Your browser doesn't support javascript.
loading
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun; Lee, Alice W; Wu, Anna H; Bandera, Elisa V; Jensen, Allan; Rossing, Mary Anne; Moysich, Kirsten B; Chang-Claude, Jenny; Doherty, Jennifer A; Gentry-Maharaj, Aleksandra; Kiemeney, Lambertus; Gayther, Simon A; Modugno, Francesmary; Massuger, Leon; Goode, Ellen L; Fridley, Brooke L; Terry, Kathryn L; Cramer, Daniel W; Ramus, Susan J; Anton-Culver, Hoda; Ziogas, Argyrios; Tyrer, Jonathan P; Schildkraut, Joellen M; Kjaer, Susanne K; Webb, Penelope M; Ness, Roberta B; Menon, Usha; Berchuck, Andrew; Pharoah, Paul D; Risch, Harvey; Pearce, Celeste Leigh.
Afiliação
  • Liu G; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan.
  • Mukherjee B; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan.
  • Lee S; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan.
  • Lee AW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Bandera EV; Cancer Prevention and Control Research Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Rossing MA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Moysich KB; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
  • Chang-Claude J; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Doherty JA; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Gentry-Maharaj A; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kiemeney L; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, New Hampshire.
  • Gayther SA; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Modugno F; Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
  • Massuger L; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Goode EL; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Fridley BL; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Terry KL; Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  • Cramer DW; Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Ramus SJ; Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  • Anton-Culver H; University of Kansas Medical Center, Kansas City, Kansas.
  • Ziogas A; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Tyrer JP; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Schildkraut JM; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Kjaer SK; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Webb PM; School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Ness RB; Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Menon U; Genetic Epidemiology Research Institute, Center for Cancer Genetics Research and Prevention, School of Medicine, University of California, Irvine, Irvine, California.
  • Berchuck A; Genetic Epidemiology Research Institute, Center for Cancer Genetics Research and Prevention, School of Medicine, University of California, Irvine, Irvine, California.
  • Pharoah PD; Strangeways Research Laboratory, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Risch H; Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, Virginia.
  • Pearce CL; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Am J Epidemiol ; 187(2): 366-377, 2018 02 01.
Article em En | MEDLINE | ID: mdl-28633381
ABSTRACT
There have been recent proposals advocating the use of additive gene-environment interaction instead of the widely used multiplicative scale, as a more relevant public health measure. Using gene-environment independence enhances statistical power for testing multiplicative interaction in case-control studies. However, under departure from this assumption, substantial bias in the estimates and inflated type I error in the corresponding tests can occur. In this paper, we extend the empirical Bayes (EB) approach previously developed for multiplicative interaction, which trades off between bias and efficiency in a data-adaptive way, to the additive scale. An EB estimator of the relative excess risk due to interaction is derived, and the corresponding Wald test is proposed with a general regression setting under a retrospective likelihood framework. We study the impact of gene-environment association on the resultant test with case-control data. Our simulation studies suggest that the EB approach uses the gene-environment independence assumption in a data-adaptive way and provides a gain in power compared with the standard logistic regression analysis and better control of type I error when compared with the analysis assuming gene-environment independence. We illustrate the methods with data from the Ovarian Cancer Association Consortium.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estudos de Casos e Controles / Projetos de Pesquisa Epidemiológica / Interação Gene-Ambiente Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estudos de Casos e Controles / Projetos de Pesquisa Epidemiológica / Interação Gene-Ambiente Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article